Skip to content

Adherence of healthcare professionals to preventive and monitoring protocols for patients with inflammatory bowel disease – the Importance of a holistic approach.

We would like to invite you to participate in a survey regarding the implementation and adherence of monitoring strategies in patients with IBD. This questionnaire consists of 31 questions (it will take you aprox 5 min), some of which allow multiple answers. Please respond accordingly. The study is completely anonymous and voluntary. The data will be collected and used to improve patient care. Thank you!
1.Your Age:
2.How do you describe yourself:
3.Which country do you practice in?
4.What is your current profession?
5.How many years of professional experience in healthcare do you have?
6.How many years of professional experience in IBD do you have?
7.In which healthcare setting do you practice?
8.What is the population of your catchment area?
9.How many patients with IBD do you manage per month?
10.Do you treat adults, children, or both?
11.When a patient is in remission, how often do you follow them up?
12.Do you recommend biochemical assesment (CRP and FCP) and anemia screening according to recent ECCO recommendations every 6-12 months in remission?
13.Do you screen for vitamin B12 and folic acid in at-risk patients (ej. after ileal resection) in remission ?
14.Do you perform upper GI endoscopy in newly diagnosed IBD patients without epigastric pain?
15.How do you monitor your patients with active disease?
16.How do you monitor your patients with quiescent disease?
17.Do you perform abdominal/intestinal ultrasound (IUS) at the diagnosis of IBD?
18.Do you perform intestinal ultrasound (IUS) during control visits?
19.What are the principal barriers to conducting IUS?
20.Can you assess flare/remission status with IUS?
21.Do you evaluate response endoscopically after initiation of treatment?
22.If yes, when after initiation of new therapy?
23.In case of suboptimal disease control do you base your decisions on STRIDE-II?
24.How do you mostly define intermediate disease control in your daily practice (multiple choice)?
25.Have you used prednisolone ≥10 mg/day (or its equivalent) for more than 8 weeks or undergone more than one course of steroids under the current therapy within the past 12 months?
26.How do you evaluate long-term remission (multiple choice)?
27.Do you have support of the dedicated IBD nurses?
28.Do you have support from a dedicated psychologist?
29.Do you have support from dietitian?
30.Do you have the opportunity to discuss patients in an IBD MDT (multidisciplinary team) meeting?
Thank you for participating in the survey!
31.Do you have any other comments, questions, or concerns?